CA9 and neoplasm: To predict the potential side effect profile of CAIX-targeting agents in humans, it will be important to establish organ-on-a-chip systems that link tumor tissue with multiple tissues in an in vitro circulation, often referred to as so-called body-on-a-chip systems [28].